2Wellington K,Goa KL.Zoledmnic acid:a review of its use in the management of bone metastases and hype rcalcaem ia of malignancy[J].Drugs,2003,63:417 ～437.
2Li EC,Davis LE.Zoledronic acid:a new parenteral bisphosphonate[J].Clin Ther,2003,25(11):2669-2708.
3Saad F.Treatment of bone complications in advanced prostate cancer:rational for bisphosphonate use and results of a phase Ⅲ trial with zoledronic acid[J].Semin Oncol,2002,29(6 Suppl 21):19-27.
4Bilston LE,Little DG,Smith NC,et al.Zoledronic acid improves the mechanical properties of normal and healing bone[J].Clin Biomech,2002,17(9-10):716-718.
5Rosen LS,Gordon D,Tchekmedyian S,et al.Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors:a phase Ⅲ,double-blind,randomized trial-the Zoledronic acid lung cancer and other solid tumors study group[J].J Clin Oncol,2003,21 (16):3150-3157.
6Rosen LS,Gordon D,Kaminski M,et al.Long-term efficacy and safety of Zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma:a randomized,double-blind,multicenter,comparative trial[J].Cancer,2003,98(8):1735-1744.
7Wardley A,Davidson N,Barrett-Lee P,et al.Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases:a randomized,crossover study of community vs hospital bisphosphonate administration[J].Br J Cancer,2005,92(10):1869-1876.
